Balchem Corporation (BCPC)
NASDAQ
Closed
Oct 19, 2026
Day's Range
169.9852 wk Range
146.21Overview - BCPC - Balchem Corporation
Key Statistics
Valuation
Enterprise Value
5.53B
P/E (Trailing)
‪33.43‬
P/E (Forward)
‪27.18‬
PEG Ratio
‪1.81‬
Price / Sales (TTM)
‪5.00‬
Price / Book
‪4.18‬
EV / EBITDA
‪20.56‬
Profitability
Profit Margin
‪15.14%‬
Operating Margin
‪20.85%‬
Return on Assets
‪8.23%‬
Return on Equity
‪12.79%‬
Ownership
Shares Outstanding
31.87M
Float
31.68M
Short % of Shares Outstanding
‪2.12%‬
Held by Insiders
‪0.49%‬
Held by Institutions
‪92.44%‬
Price stats
Beta
‪0.85‬
50-Day Avg
‪172.07‬
200-Day Avg
‪168.43‬
Dividends
Payout Ratio
‪18.90%‬
Frequency
Annual
Analyst Consensus
3 analysts
Average price target
‪$ 209.25‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BCPC - Balchem Corporation
Peers - BCPC - Balchem Corporation
Peer Comparison
Compared with companies in Specialty Chemicals listed on NASDAQ.
Profile Summary - BCPC - Balchem Corporation
About
Balchem Corporation is a specialty ingredients and solutions company that develops, manufactures, and distributes performance products for nutrition, food, pharmaceuticals, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three main segments: Human…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
